PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)
| Subclass | Title |
|---|---|
| 1/00 | General processes for the preparation of peptides |
| 1/02 | General processes for the preparation of peptides in solution |
| 1/04 | General processes for the preparation of peptides on carriers |
| 1/06 | General processes for the preparation of peptides using protecting groups or activating agents |
| 1/08 | General processes for the preparation of peptides using protecting groups or activating agents using activating agents |
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 9,119,869 | Mucin derived polypeptides | Apr 29, 11 | Sep 01, 15 | Not available |
| 9,119,884 | LLP2A-bisphosphonate conjugates for osteoporosis treatment | Jan 19, 12 | Sep 01, 15 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 9,119,885 | RGD-containing peptidomimetics and uses thereof | Feb 07, 14 | Sep 01, 15 | STEBA BIOTECH S.A. |
| 9,119,886 | Immunoconjugates for the treatment of tumours | Apr 30, 10 | Sep 01, 15 | MOLMED S.P.A. |
| 9,120,818 | Process and intermediates for preparing macrolactams | Dec 13, 11 | Sep 01, 15 | MERCK SHARP & DOHME CORP. |
| 9,120,840 | Methods for selective targeting | Mar 31, 10 | Sep 01, 15 | DANISCO US INC. |
| 9,120,841 | Amphiphilic linear peptidepeptoid and hydrogel comprising the same | Dec 31, 12 | Sep 01, 15 | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
| 9,120,842 | SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same | May 23, 13 | Sep 01, 15 | ONCO THERAPY SCIENCE, INC. |
| 9,120,843 | Agent derived from tortoise spleen stimulating mammalian hemopoiesis | Aug 11, 14 | Sep 01, 15 | BMR SOLUTIONS LTD. |
| 9,120,844 | Method for changing conformation of globular proteins | May 24, 12 | Sep 01, 15 | NATIONAL CHENG KUNG UNIVERSITY |
| 9,120,845 | Polymers and plastics derived from animal proteins | May 14, 12 | Sep 01, 15 | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA |
| 9,120,846 | Neutral zwitterionic displacer molecules for hydrophobic displacement chromatography | Oct 03, 12 | Sep 01, 15 | SACHEM, INC. |
| 9,120,847 | Isolation of phosphoproteins, glycoproteins and fragments thereof | Jan 17, 13 | Sep 01, 15 | |
| 9,120,848 | Non-aqueous synthesis of polysaccharide-protein conjugates for vaccines | Sep 22, 11 | Sep 01, 15 | |
| 9,120,849 | Nucleic acid amplification controls | Oct 30, 07 | Sep 01, 15 | ZEPTOMETRIX CORPORATION |
| 9,120,850 | Biosensor for detection and visualisation of single-stranded DNA | Jun 11, 08 | Sep 01, 15 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, |
| 9,120,851 | Human antibodies to human angiopoietin-like protein 4 | Dec 12, 12 | Sep 01, 15 | REGENERON PHARMACEUTICALS, INC. |
| 9,120,852 | Antibody for the diagnosis and/or prognosis of cancer | Jun 29, 11 | Sep 01, 15 | PIERRE FABRE MEDICAMENT |
| 9,120,853 | Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof | Apr 26, 13 | Sep 01, 15 | CYTOMX THERAPEUTICS, INC. |
| 9,120,854 | Detection and treatment of pancreatic, ovarian and other cancers | Apr 10, 09 | Sep 01, 15 | SEATTLE GENETICS, INC. |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2015/0245,598 | Genetically Modified Major Histocompatibility Complex Animals | Apr 20, 15 | Sep 03, 15 | REGENERON PHARMACEUTICALS, INC. |
| 2015/0245,596 | MELANOCORTIN RECEPTOR MUTANT MOUSE AND USES THEREOF | Sep 17, 13 | Sep 03, 15 | THE GENERAL HOSPITAL CORPORATION |
| 2015/0245,852 | SPERM ACTIVATING AGENT AND ACTIVATING METHOD USING SAME | Sep 19, 13 | Sep 03, 15 | NATIONAL UNIVERSITY CORPORATION HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE |
| 2015/0246,091 | COMPOUNDS AND METHODS FOR PREVENTING OR TREATING A VIRAL INFECTION | May 15, 15 | Sep 03, 15 | |
| 2015/0246,092 | METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH | Oct 22, 13 | Sep 03, 15 | |
| 2015/0246,945 | PEPTIDES THAT BIND TO EPITHELIAL CELL ADHESION MOLECULE | Sep 12, 13 | Sep 03, 15 | JAPANESE FOUNDATION FOR CANCER RESEARCH |
| 2015/0246,946 | PEPTIDES AND METHODS FOR TREATING CANCER | Oct 01, 13 | Sep 03, 15 | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
| 2015/0246,947 | PEPTIDES AND METHODS OF USE | Feb 27, 15 | Sep 03, 15 | BAXALTA INCORPORATED, |
| 2015/0246,948 | POLYPEPTIDES AND ANTIBODIES FOR TREATING HBV INFECTION AND RELATED DISEASES | Jun 06, 13 | Sep 03, 15 | XIAMEN INNOVAX BIOTECH CO., LTD., |
| 2015/0246,949 | Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor | Sep 24, 13 | Sep 03, 15 | UNIVERSITY OF WASHINGTON |
| 2015/0246,950 | Chimeric Dystrophin-VSV-G Protein to Treat Dystrophinopathies | Mar 02, 15 | Sep 03, 15 | |
| 2015/0246,951 | LOCALIZATION AND CHARACTERIZATION OF FLAVIVIRUS ENVELOPE GLYCOPROTEIN CROSS-REACTIVE EPITOPES AND METHODS FOR THEIR USE | Mar 16, 15 | Sep 03, 15 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT |
| 2015/0246,952 | MEANS AND METHODS FOR BREAKING NONCOVALENT BINDING INTERACTIONS BETWEEN MOLECULES | May 05, 15 | Sep 03, 15 | |
| 2015/0246,953 | IMMUNOGLOBULJIN-BINDING HUMAN MYCOPLASMA ANTIGENS AND METHODS OF USE THEREOF | Jul 16, 13 | Sep 03, 15 | THE SCRIPPS RESEARCH INSTITUTE |
| 2015/0246,954 | INSECTICIDAL PROTEINS DERIVED FROM BACILLUS THURINGIENSIS | Mar 10, 15 | Sep 03, 15 | |
| 2015/0246,955 | METHODS AND COMPOSITIONS FOR SPECIFIC MODULATION OF MCL-1 | May 15, 15 | Sep 03, 15 | DANA-FARBER CANCER INSTITUTE, INC. |
| 2015/0246,956 | USE OF IL-15 PREPARATIONS TO TREAT LYMPHOPENIA | Oct 13, 14 | Sep 03, 15 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT |
| 2015/0246,957 | PARATHYROID HORMONE, INSULIN, AND RELATED PEPTIDES CONJUGATED TO BONE TARGETING MOIETIES AND METHODS AND MAKING AND USING THEREOF | Aug 28, 13 | Sep 03, 15 | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA |
| 2015/0246,958 | BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS | Dec 05, 14 | Sep 03, 15 | BAIKANG (SUZHOU) CO., LTD |
| 2015/0246,959 | T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3 | Sep 13, 13 | Sep 03, 15 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT |
